# EDGAR Filing Document

**Accession Number:** 0000912544
**File Stem:** 0000000000-23-002105
**Filing Date:** 2023-3
**Character Count:** 7726
**Document Hash:** 740fdd43b71b4c1338c02fdecd513b39
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-23-002105.hdr.sgml**: 20230803

**ACCESSION NUMBER**: 0000000000-23-002105

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230302

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NovelStem International Corp.
- **CENTRAL INDEX KEY:** 0000912544
- **STANDARD INDUSTRIAL CLASSIFICATION:** RETAIL-RETAIL STORES, NEC [5990]
- **IRS NUMBER:** 650385686
- **STATE OF INCORPORATION:** FL
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD

**BUSINESS ADDRESS:**
- **STREET 1:** 2255 GLADES RD
- **STREET 2:** STE 237 W
- **CITY:** BOCA RATON
- **STATE:** FL
- **ZIP:** 33431
- **BUSINESS PHONE:** 5619988000

**MAIL ADDRESS:**
- **STREET 1:** 2255 GLADES RD
- **STREET 2:** STE 237 W
- **CITY:** BOCA RATON
- **STATE:** FL
- **ZIP:** 33431

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NovelStem International Corp
- **DATE OF NAME CHANGE:** 20220802

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HOLLYWOOD MEDIA CORP
- **DATE OF NAME CHANGE:** 20001215

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HOLLYWOOD COM INC
- **DATE OF NAME CHANGE:** 20000511
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001493152-22-020936

## Text-Extract

```

United States securities and exchange commission logo

                             March 2, 2023

       Jan Loeb
       Executive Chairman
       NovelStem International Corp.
       2255 Glades Road
       Suite 221A
       Boca Raton, FL 33431

                                                        Re: NovelStem
International Corp.
                                                            Amendment No. 3 to
Registration Statement on Form 10-12G
                                                            Correspondence
Filed February 17, 2023
                                                            File No. 000-22908

       Dear Jan Loeb:

             We have reviewed your filing and have the following comment. In
our comment, we
       may ask you to provide us with information so we may better understand
your disclosure.

              Please respond to this comment within ten business days by
providing the requested
       information or advise us as soon as possible when you will respond. If
you do not believe our
       comment applies to your facts and circumstances, please tell us why in
your response.

              After reviewing your response and any amendment you may file in
response to
       this comment, we may have additional comments.

       Amendment No. 3 to Registration Statement on Form 10-12G

       General

   1.                                                   We note your response
to our prior Comment 1, which requested an analysis of whether
                                                        NewStem is
controlled primarily    by Novelstem for purposes of Rule 3a-1(a)(4) under
                                                        the 1940 Act. Your
response does not provide the staff with a sufficient basis to evaluate
                                                        this question. To that
end, please provide relevant details regarding Novelstem   s rights as
                                                        a shareholder and board
member of NewStem relative to those of the Founders (as defined
                                                        NewStem   s Articles of
Incorporation). Your response should, at minimum, include a
                                                        discussion of (i) the
relative voting power of the Major Shareholders (as defined
                                                        NewStem   s Articles of
Incorporation) and address whether Novelstem has satisfied the
                                                        conditions included in
Section 40.2 of NewStem   s Articles of Incorporation, (ii) who has
 Jan Loeb
NovelStem International Corp.
March 2, 2023
Page 2
      the right to appoint senior officers or senior management of NewStem, and
(iii) who (if
      anyone) has the right to approve or reject major NewStem corporate
actions.
        We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence of
action by the staff.

       You may contact Suying Li at 202-551-3335 or Rufus Decker at
202-551-3769 if you
have questions regarding comments on the financial statements and related
matters. Please
contact Nicholas Nalbantian at 202-551-7470 or Erin Jaskot at 202-551-3442 with
any other
questions.

                                                           Sincerely,
FirstName LastNameJan Loeb
                                                           Division of
Corporation Finance
Comapany NameNovelStem International Corp.
                                                           Office of Trade &
Services
March 2, 2023 Page 2
cc:       Morris DeFeo
FirstName LastName

```

### Attached PDF Documents

**Attachment 1:** `filename1`

![img-0.jpeg](img-0.jpeg)

CORPORATION FINANCE

# UNITED STATES  
SECURITIES AND EXCHANGE COMMISSION  
WASHINGTON, D.C. 20549

March 2, 2023

Jan Loeb  
Executive Chairman  
NovelStem International Corp.  
2255 Glades Road  
Suite 221A  
Boca Raton, FL 33431

# **Re: NovelStem International Corp.  
Amendment No. 3 to Registration Statement on Form 10-12G  
Correspondence Filed February 17, 2023  
File No. 000-22908**

Dear Jan Loeb:

We have reviewed your filing and have the following comment. In our comment, we may ask you to provide us with information so we may better understand your disclosure.

Please respond to this comment within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe our comment applies to your facts and circumstances, please tell us why in your response.

After reviewing your response and any amendment you may file in response to this comment, we may have additional comments.

# Amendment No. 3 to Registration Statement on Form 10-12G

# General

1. We note your response to our prior Comment 1, which requested an analysis of whether NewStem is “controlled primarily” by Novelstem for purposes of Rule 3a-1(a)(4) under the 1940 Act. Your response does not provide the staff with a sufficient basis to evaluate this question. To that end, please provide relevant details regarding Novelstem’s rights as a shareholder and board member of NewStem relative to those of the Founders (as defined NewStem’s Articles of Incorporation). Your response should, at minimum, include a discussion of (i) the relative voting power of the Major Shareholders (as defined NewStem’s Articles of Incorporation) and address whether Novelstem has satisfied the conditions included in Section 40.2 of NewStem’s Articles of Incorporation, (ii) who has

Jan Loeb
NovelStem International Corp.
March 2, 2023
Page 2

the right to appoint senior officers or senior management of NewStem, and (iii) who (if anyone) has the right to approve or reject major NewStem corporate actions.

We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

You may contact Suying Li at 202-551-3335 or Rufus Decker at 202-551-3769 if you have questions regarding comments on the financial statements and related matters. Please contact Nicholas Nalbantian at 202-551-7470 or Erin Jaskot at 202-551-3442 with any other questions.

Sincerely,

Division of Corporation Finance
Office of Trade & Services

cc: Morris DeFeo